Investing in Medpace Holdings, Inc. (MEDP)  ➔  Intrinsic value

Prev. close$198.21 
ModelValueUpside
Chepakovich$29.85-85%
Graham-Dodd$23.13-88%
Graham$140.03-29%
Previous Close$198.21  
Valuation MethodValuePotential 
Chepakovich Model$29.85-85%recalculate
Graham-Dodd$23.13-88%recalculate
Graham Formula$140.03-29%recalculate

Latest news

Company description

Medpace Holdings, Inc., a clinical contract research organization, provides scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries worldwide. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It also provides clinical development services; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. The company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is headquartered in Cincinnati, Ohio.